Pfizer Stock Hits 52-Week High Amid Broad Pharmaceutical Rally

Key Facts

1Pfizer shares reached a new 52-week high on Thursday as drugmakers rallied broadly across the market.

2The upward movement follows the FDA's approval of a Tukysa regimen announced one week prior.

Pfizer shares reached a new 52-week high on Thursday as drugmakers rallied broadly across the market. Benzinga reported that the upward movement follows the FDA's approval of a Tukysa regimen announced one week prior, which has continued to support investor sentiment.

PFE closed at $29.21 on October 14, 2026, ahead of the surge to its new annual peak. During that session, the stock traded between a low of $28.55 and a high of $29.49, reflecting the broader strength currently observed in the healthcare sector.